Clinical Trial: Hypertension in Hemodialysis


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Hypertension in Hemodialysis

This study is currently recruiting patients.

Sponsored by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

How we should diagnose high blood pressure in hemodialysis patients and treat it using medications or without medications is the purpose of this study

Condition	Treatment or Intervention
Hypertension hemodialysis Left Ventricular Hypertrophy	Procedure: Ultrafiltration Drug: ACE inhibitors or beta blockers

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Further Study Details:

Expected Total Enrollment: 150

Study start: August 2003

Eligibility

Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both

Criteria

adults hypertension hemodialysis

Location and Contact Information

Indiana
Indiana University Affiliated Dialysis Unit, Indianapolis, Indiana, 46202, United States; Recruiting

Rajiv Agarwal, MD 317-554-0000 Ext. 2241
Rajiv Agarwal, MD, Principal Investigator

More Information

Study ID Numbers: 1
Record last reviewed: August 2004
Record first received: August 25, 2003
ClinicalTrials.gov Identifier: NCT00067665
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services